financetom
Business
financetom
/
Business
/
Hims & Hers Health Insider Sold Shares Worth $6,907,500, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hims & Hers Health Insider Sold Shares Worth $6,907,500, According to a Recent SEC Filing
Jul 9, 2024 12:34 AM

03:10 AM EDT, 07/09/2024 (MT Newswires) -- Andrew Dudum, 10% Owner, Director, Chief Executive Officer, on July 03, 2024, sold 333,332 shares in Hims & Hers Health ( HIMS ) for $6,907,500. Following the Form 4 filing with the SEC, Dudum has control over a total of 10,986,089 shares of the company, with 33,502 shares held directly and 10,952,587 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1773751/000177375124000217/xslF345X03/wk-form4_1720478714.xml

Price: 20.48, Change: -0.03, Percent Change: -0.15

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Honda Motor Reportedly Expects to Double EV Driving Range Before Decade Ends
Honda Motor Reportedly Expects to Double EV Driving Range Before Decade Ends
Nov 21, 2024
06:54 AM EST, 11/21/2024 (MT Newswires) -- Honda Motor ( HMC ) is looking to double the driving range of its electric cars by the late 2020s when they start to mass produce all-solid-state batteries, media outlets reported Wednesday. All-solid-state batteries are expected to produce twice the driving range by the end of 2030 and over 2.5 times more by...
Origin Materials Insider Bought Shares Worth $300,000, According to a Recent SEC Filing
Origin Materials Insider Bought Shares Worth $300,000, According to a Recent SEC Filing
Nov 21, 2024
07:12 AM EST, 11/21/2024 (MT Newswires) -- Richard J. Riley, Director, CO-CEO AND DIRECTOR, on November 20, 2024, executed a purchase for 300,000 shares in Origin Materials ( ORGN ) for $300,000. Following the Form 4 filing with the SEC, Riley has control over a total of 2,774,985 shares of the company, with 1,318,070 shares held directly and 1,456,915 shares...
Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
Nov 21, 2024
07:12 AM EST, 11/21/2024 (MT Newswires) -- Zymeworks ( ZYME ) and Jazz Pharmaceuticals (JAZZ) said Thursday they have received accelerated approval for Ziihera from the US Food and Drug Administration to treat adult patients with previously-treated, unresectable or metastatic HER2-positive biliary tract cancer. The regulator's approval was based on the HERIZON-BTC-01 trial of Ziihera, which evaluated zanidatamab as a...
RTX's Pratt & Whitney to Explore Upgrading F100 Engine Maintenance, Overhaul Capacity
RTX's Pratt & Whitney to Explore Upgrading F100 Engine Maintenance, Overhaul Capacity
Nov 21, 2024
07:13 AM EST, 11/21/2024 (MT Newswires) -- RTX (RTX) subsidiary Pratt & Whitney said Thursday it has signed a letter of intent with Wojskowe Zaklady Lotnicze to explore an expansion of maintenance repair and overhaul capabilities to meet increased Polish Air Force needs for the F100 engines powering its F-16 fleet. No financial details were disclosed. Piotr Owsicki, general director...
Copyright 2023-2026 - www.financetom.com All Rights Reserved